Who owns SENTI BIOSCIENCES ORD?

Tip: Access positions for across all investors

Analyze quarterly positions in Senti Biosciences Ord with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Senti Biosciences Ord stock

Who bought or sold SENTI BIOSCIENCES ORD this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
NEA Management Company 4.4M $1.7M 0% Mar 2024
 View chart
8vc Gp I 2.5M $957k 0% Mar 2024
 View chart
ARK Investment Management 1.6M $615k -17% Mar 2024
 View chart
Vanguard Group 707k $267k 0% Mar 2024
 View chart
Intel Corporation 596k $225k 0% Mar 2024
 View chart
Triatomic Management 311k $117k 0% Mar 2024
 View chart
Geode Capital Management 246k $93k 3% Mar 2024
 View chart
Omega Fund Management 196k $129k 0% Dec 2023
 View chart
Bridgeway Capital Management 145k $55k 0% Mar 2024
 View chart
Two Sigma Investments 94k $35k 227% Mar 2024
 View chart
Citadel Advisors 79k $30k 81% Mar 2024
 View chart
BlackRock 40k $15k 0% Mar 2024
 View chart
Northern Trust 37k $14k 0% Mar 2024
 View chart
Allen Operations 21k $8.1k 0% Mar 2024
 View chart
Harbour Investments 15k $9.9k 50% Dec 2023
 View chart
Millennium Management 13k $5.0k -7% Mar 2024
 View chart
Tower Research Capital 8.5k $3.2k 100% Mar 2024
 View chart
Morgan Stanley 1.6k $603.040000 159900% Mar 2024
 View chart
Citigroup 1.3k $505.046000 100% Mar 2024
 View chart
Wolverine Asset Management 800.00 $300.960000 0% Mar 2024
 View chart
UBS Group 732.00 $275.964000 100% Mar 2024
 View chart
Bank of America Corporation 241.00 $91.411300 -95% Mar 2024
 View chart
Wells Fargo & Company 202.00 $75.992400 2% Mar 2024
 View chart
Brian McDonald 48.00 $18.000000 0% Mar 2024
 View chart

Who sold out of Senti Biosciences Ord?

Fund or Company Name Date Sold Shares Held Valued At
Artal Group Dec 2023 56k $37k
Bank of New York Mellon Dec 2023 12k $8.2k